Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack T Adams

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 5, 2024
Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networksLea M Stitzlein, Jack T Adams, Erin N Stitzlein, et al.
Cancers|November 27, 2025
RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA DamageVahid Khalaj, Jack T Adams, Solmaz AghaAmiri, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic ApplicationsServando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
Cancers|January 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular CarcinomaMajid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Experimental & Clinical Cancer Research : CR|January 5, 2024
Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networksLea M Stitzlein, Jack T Adams, Erin N Stitzlein, et al.
Cancers|November 27, 2025
RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA DamageVahid Khalaj, Jack T Adams, Solmaz AghaAmiri, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic ApplicationsServando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
Cancers|January 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular CarcinomaMajid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas, et al.
Pageof 1